| Farres Nitam Uddin Ahmed, MD | |
|
2874 N Carson St Ste 300, Carson City, NV 89706 | |
| (775) 445-5500 | |
| (775) 888-0202 |
| Full Name | Farres Nitam Uddin Ahmed |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 2874 N Carson St Ste 300, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851646657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 18110 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
| Northern Inyo Hospital | Bishop, CA | Hospital |
| Black Hills Surgical Hospital Llp | Rapid city, SD | Hospital |
| Mount Grant General Hospital | Hawthorne, NV | Hospital |
| Mayers Memorial Hospital | Fall river mills, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| High Desert Imaging Llc | 2769781244 | 10 |
| Tahoe Carson Radiology Loos Et Al Ltd | 6406832591 | 12 |
| Northern Inyo Healthcare District | 8921992090 | 86 |
| Tahoe Carson Radiology Loos Et Al Ltd | 6406832591 | 12 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
A new study available on the pre-print server medRxiv* aims to assess the specificity of the serological assays of SARS-CoV-2 antibodies among patients known to have a tissue-borne parasitic infection or those who reside in areas where the virus is endemic.
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
A new study in Frontiers in Public Health presents a review of expert opinions on the achievements and shortcomings of the European Union's (EU) COVID-19 response. The aim: to draw lessons for future pandemics.
There is now a new alternative to immunosuppressive treatment after kidney transplants which comes without the usual severe side effects. The Medical University was significantly involved in the clinical development of the active ingredient Belatacept and a suitable preparation has now been given EU-wide authorisation.
› Verified 7 days ago
| Entity Name | Tahoe Carson Radiology Loos Et Al Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902838352 PECOS PAC ID: 6406832591 Enrollment ID: O20040629000218 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
A new study available on the pre-print server medRxiv* aims to assess the specificity of the serological assays of SARS-CoV-2 antibodies among patients known to have a tissue-borne parasitic infection or those who reside in areas where the virus is endemic.
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
A new study in Frontiers in Public Health presents a review of expert opinions on the achievements and shortcomings of the European Union's (EU) COVID-19 response. The aim: to draw lessons for future pandemics.
There is now a new alternative to immunosuppressive treatment after kidney transplants which comes without the usual severe side effects. The Medical University was significantly involved in the clinical development of the active ingredient Belatacept and a suitable preparation has now been given EU-wide authorisation.
› Verified 7 days ago
| Entity Name | High Desert Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134589716 PECOS PAC ID: 2769781244 Enrollment ID: O20160504002551 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
A new study available on the pre-print server medRxiv* aims to assess the specificity of the serological assays of SARS-CoV-2 antibodies among patients known to have a tissue-borne parasitic infection or those who reside in areas where the virus is endemic.
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
A new study in Frontiers in Public Health presents a review of expert opinions on the achievements and shortcomings of the European Union's (EU) COVID-19 response. The aim: to draw lessons for future pandemics.
There is now a new alternative to immunosuppressive treatment after kidney transplants which comes without the usual severe side effects. The Medical University was significantly involved in the clinical development of the active ingredient Belatacept and a suitable preparation has now been given EU-wide authorisation.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Farres Nitam Uddin Ahmed, MD Po Box 1626, Evansville, IN 47706-0028 Ph: (775) 445-5500 | Farres Nitam Uddin Ahmed, MD 2874 N Carson St Ste 300, Carson City, NV 89706 Ph: (775) 445-5500 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
A new study available on the pre-print server medRxiv* aims to assess the specificity of the serological assays of SARS-CoV-2 antibodies among patients known to have a tissue-borne parasitic infection or those who reside in areas where the virus is endemic.
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
A new study in Frontiers in Public Health presents a review of expert opinions on the achievements and shortcomings of the European Union's (EU) COVID-19 response. The aim: to draw lessons for future pandemics.
There is now a new alternative to immunosuppressive treatment after kidney transplants which comes without the usual severe side effects. The Medical University was significantly involved in the clinical development of the active ingredient Belatacept and a suitable preparation has now been given EU-wide authorisation.
› Verified 7 days ago
Betsy Card, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-445-5500 Fax: 775-888-0202 | |
Thomas Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-888-1180 Fax: 775-852-6902 | |
Dr. Sandra Jill Althaus, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St, Suite 300, Carson City, NV 89706 Phone: 775-445-5500 Fax: 775-852-6902 | |
Stephen Loos, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-888-1180 Fax: 775-852-6902 | |
Gary Eugene Turner, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-888-1180 Fax: 775-852-6902 | |
David N Landis, MD Radiology Medicare: Medicare Enrolled Practice Location: 2874 N Carson St Ste 300, Carson City, NV 89706 Phone: 775-445-5500 Fax: 775-852-6902 | |
Mrs. Beth L Hummer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1535 Medical Pkwy Ste A, Carson City, NV 89703 Phone: 775-883-5505 Fax: 775-883-6779 |